Proposed diagnostic criteria for neurocysticercosis

被引:556
作者
Del Brutto, OH
Rajshekhar, V
White, AC
Tsang, VCW
Nash, TE
Takayanagui, OM
Schantz, PM
Evans, CAW
Flisser, A
Correa, D
Botero, D
Allan, JC
Sarti, E
Gonzalez, AE
Gilman, RH
García, HH
机构
[1] Hosp Clin Kennedy, Dept Neurol Sci, Guayaquil, Ecuador
[2] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India
[3] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA
[4] Ctr Dis Control, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[5] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[6] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol, BR-05508 Sao Paulo, Brazil
[7] Univ Cambridge, Sch Clin, Cambridge, England
[8] Secretaria Salud, Inst Diagnost & Referencia Epidemiol, Mexico City, DF, Mexico
[9] Secretaria Salud, Direcc Gen Epidemiol, Mexico City, DF, Mexico
[10] Inst Colombiano Med Trop, Medellin, Colombia
[11] Pfizer Global Res & Dev, Sandwich, Kent, England
[12] Univ Nacl Mayor San Marcos, Lima 14, Peru
[13] Asociac Benefica Proyectos Informat Salud Med & A, Lima, Peru
[14] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[15] Inst Nacl Ciencias Neurol, Cysticercosis Unit, Lima, Peru
[16] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru
[17] Univ Peruana Cayetano Heredia, Dept Pathol, Lima, Peru
基金
英国惠康基金;
关键词
D O I
10.1212/WNL.57.2.177
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurocysticercosis is the most common helminthic infection of the CNS but its diagnosis remains difficult. Clinical manifestations are nonspecific, most neuroimaging findings are not pathognomonic, and some serologic tests have low sensitivity and specificity. The authors provide diagnostic criteria for neurocysticercosis based on objective clinical, imaging, immunologic, and epidemiologic data. These include four categories of criteria stratified on the basis of their diagnostic strength, including the following: 1) absolute-histologic demonstration of the parasite from biopsy of a brain or spinal cord lesion, cystic lesions showing the scolex on CT or MRI, and direct visualization of subretinal parasites by funduscopic examination; 2) major-lesions highly suggestive of neurocysticercosis on neuroimaging studies, positive serum enzyme-linked immunoelectrotransfer blot for the detection of anticysticercal antibodies, resolution of intracranial cystic lesions after therapy with albendazole or praziquantel, and spontaneous resolution of small single enhancing lesions; 3) minor-lesions compatible with neurocysticercosis on neuroimaging studies, clinical manifestations suggestive of neurocysticercosis, positive CSF enzyme-linked immunosorbent assay for detection of anticysticercal antibodies or cysticercal antigens, and cysticercosis outside the CNS; and 4) epidemiologic-evidence of a household contact with Taenia solium infection, individuals coming from or living in an area where cysticercosis is endemic, and history of frequent travel to disease-endemic areas. Interpretation of these criteria permits two degrees of diagnostic certainty: 1) definitive diagnosis, in patients who have one absolute criterion or in those who have two major plus one minor and one epidemiologic criterion; and 2) probable diagnosis, in patients who have one major plus two minor criteria, in those who have one major plus one minor and one epidemiologic criterion, and in those who have three minor plus one epidemiologic criterion.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 63 条
[1]  
ADAMOLEKUM B, 1994, EPILEPSIA, V35, P89
[2]   IMMUNODIAGNOSIS OF TAENIASIS BY COPROANTIGEN DETECTION [J].
ALLAN, JC ;
AVILA, G ;
NOVAL, JG ;
FLISSER, A ;
CRAIG, PS .
PARASITOLOGY, 1990, 101 :473-477
[3]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[4]  
ARRUDA W O, 1991, Arquivos de Neuro-Psiquiatria, V49, P251
[5]   Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial [J].
Baranwal, AK ;
Singhi, PD ;
Khandelwal, N ;
Singhi, SC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (08) :696-700
[6]   SHORT-COURSE ALBENDAZOLE TREATMENT FOR NEUROCYSTICERCOSIS IN COLUMBIA [J].
BOTERO, D ;
URIBE, CS ;
SANCHEZ, JL ;
ALZATE, T ;
VELASQUEZ, G ;
OCAMPO, NE ;
VILLA, LA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (05) :576-577
[7]   A 23-year-old man with seizures and a lesion in the left temporal lobe - Neurocysticercosis, left temporal lobe end-stage with calcification. Epilepsy. [J].
Bromfield, EB ;
Vonsattel, JP ;
Gonzalez, RG ;
Cole, AJ ;
Hoch, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (06) :420-427
[8]  
Carpio A, 1998, J NEUROL SCI, V161, P185, DOI 10.1016/S0022-510X(98)00227-5
[9]  
COKER-VANN M R, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P499
[10]   ANTICYSTICERCOUS ANTIBODIES IN SERUM AND CEREBROSPINAL-FLUID IN PATIENTS WITH CEREBRAL CYSTICERCOSIS [J].
CORONA, T ;
PASCOE, D ;
GONZALEZBARRANCO, D ;
ABAD, P ;
LANDA, L ;
ESTANOL, B .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (09) :1044-1049